| Company Name: |
TCI Europe |
| Tel: |
320-37350700 |
| Email: |
sales@tcieurope.eu |
| Company Name: |
TCI AMERICA |
| Tel: |
800-4238616 |
| Email: |
sales@tciamerica.com |
|
| | Lipoamido-PEG12-carboxylic Acid Basic information |
| Product Name: | Lipoamido-PEG12-carboxylic Acid | | Synonyms: | Lipoamido-PEG12-acid;Lipoamido-PEG12-carboxylic Acid;45-(1,2-Dithiolan-3-yl)-41-oxo-4,7,10,13,16,19,22,25,28,31,34,37-dodecaoxa-40-azapentatetracontan-1-oic Acid;Carboxy-PEG12-lipoamide;Lipoamido-dPEG12-acid;Lipoamido-PEG12-CH2CH2COOH | | CAS: | 2407442-47-9 | | MF: | C35H67NO15S2 | | MW: | 806.03 | | EINECS: | | | Product Categories: | | | Mol File: | 2407442-47-9.mol |  |
| | Lipoamido-PEG12-carboxylic Acid Chemical Properties |
| Boiling point | 841.2±65.0 °C(Predicted) | | density | 1.155±0.06 g/cm3(Predicted) | | form | powder to crystal | | pka | 4.28±0.10(Predicted) | | color | White to Orange to Green |
| | Lipoamido-PEG12-carboxylic Acid Usage And Synthesis |
| Uses | Lipoamido-PEG12-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. | | IC 50 | PEGs | | References | [1] An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 DOI:10.1016/j.ebiom.2018.09.005 |
| | Lipoamido-PEG12-carboxylic Acid Preparation Products And Raw materials |
|